Cerenome Launches CNSide CSF Molecular Profile Tests

CNSide Diagnostics, a subsidiary of Cerenome, announced the commercial launch of its CNSide® CSF Molecular Profile Tests. These new DNA and RNA tests expand the company's CNSide offering beyond leptomeningeal metastases to encompass molecular profiling across CNS oncology.